Koshelnick Y - Search Results

1

Mechanisms of signaling through urokinase receptor and the cellular response.

Koshelnick Y, Ehart M, Stockinger H, Binder BR. Koshelnick Y, et al. Thromb Haemost. 1999 Aug;82(2):305-11. Thromb Haemost. 1999. PMID: 10605718 Review. No abstract available.

2

Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598.

Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR. Koshelnick Y, et al. J Biol Chem. 1997 Nov 7;272(45):28563-7. doi: 10.1074/jbc.272.45.28563. J Biol Chem. 1997. PMID: 9353320 Free article.

3

Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein.

Prager GW, Mihaly J, Brunner PM, Koshelnick Y, Hoyer-Hansen G, Binder BR. Prager GW, et al. Among authors: koshelnick y. Blood. 2009 Feb 5;113(6):1383-90. doi: 10.1182/blood-2008-06-164210. Epub 2008 Oct 23. Blood. 2009. PMID: 18948573 Free article.

4

Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.

Wojta J, Kaun C, Breuss JM, Koshelnick Y, Beckmann R, Hattey E, Mildner M, Weninger W, Nakamura T, Tschachler E, Binder BR. Wojta J, et al. Among authors: koshelnick y. Lab Invest. 1999 Apr;79(4):427-38. Lab Invest. 1999. PMID: 10211995

5

Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli.

Oitzinger W, Hofer-Warbinek R, Schmid JA, Koshelnick Y, Binder BR, de Martin R. Oitzinger W, et al. Among authors: koshelnick y. Blood. 2001 Mar 15;97(6):1611-7. doi: 10.1182/blood.v97.6.1611. Blood. 2001. PMID: 11238099 Free article.

6

The isoprostane 8-iso-PGF(2alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation.

Leitinger N, Huber J, Rizza C, Mechtcheriakova D, Bochkov V, Koshelnick Y, Berliner JA, Binder BR. Leitinger N, et al. Among authors: koshelnick y. FASEB J. 2001 May;15(7):1254-6. doi: 10.1096/fj.00-0498fje. FASEB J. 2001. PMID: 11344105 No abstract available.

7

Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model.

Breuss JM, Cejna M, Bergmeister H, Kadl A, Baumgartl G, Steurer S, Xu Z, Koshelnick Y, Lipp J, De Martin R, Losert U, Lammer J, Binder BR. Breuss JM, et al. Among authors: koshelnick y. Circulation. 2002 Feb 5;105(5):633-8. doi: 10.1161/hc0502.102966. Circulation. 2002. PMID: 11827931

8

NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells.

Lucerna M, Mechtcheriakova D, Kadl A, Schabbauer G, Schäfer R, Gruber F, Koshelnick Y, Müller HD, Issbrücker K, Clauss M, Binder BR, Hofer E. Lucerna M, et al. Among authors: koshelnick y. J Biol Chem. 2003 Mar 28;278(13):11433-40. doi: 10.1074/jbc.M204937200. Epub 2002 Nov 8. J Biol Chem. 2003. PMID: 12427750 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page